Search
Sunday 10 May 2015
  • :
  • :
Latest Update

Losing Stocks Buzz - Autohome, (NYSE:ATHM), Realogy Holdings, (NYSE:RLGY), Juno Therapeutics, (NASDAQ:JUNO)

On Tuesday, Shares of Autohome Inc. (NYSE:ATHM), loss -4% to $52.82.

Autohome, declared that it will report its financial results for the first quarter of 2015 before the U.S. market opens on May 6, 2015. Autohome’s administration team will host an earnings conference call at 8:00 AM on Wednesday, May 6, 2015, U.S. Eastern Time (8:00 PM on Wednesday, May 6, 2015, Beijing Time).

Autohome Inc. operates as an online destination for automobile consumers in the People’s Republic of China. The company, through its Websites, autohome.com.cn and che168.com, delivers independent and interactive content to automobile buyers and owners, counting professionally produced content that comprises automobile-related articles and reviews, pricing trends in various markets, and photos and video clips.

Shares of Realogy Holdings Corp. (NYSE:RLGY), declined -4% to $45.39, during its last trading session.

Realogy Holdings, stated financial results for the first quarter ended March 31, 2015, counting the following highlights:

  • Revenue of $1.1 billion, which represents a 5% enhance contrast to first quarter 2014, was driven by higher homesale transaction volume.
  • Adjusted EBITDA was $70 million, contrast to $53 million in the first quarter of 2014, a year-over-year enhance of 32%.
  • Net loss for first quarter 2015 was $32 million, and basic loss per share was $0.22.
  • Realogy’s franchise (RFG) and company-owned (NRT) business segments achieved a 10% enhance in combined homesale transaction volume (transaction sides multiplied by average sale price) contrast to first quarter 2014. RFG and NRT stated homesale transactions enhances of 4% and 6% and average homesale price enhances of 6% and 3%, respectively.

Realogy Holdings Corp. provides real estate and relocation services worldwide. The company’s Real Estate Franchise Services segment franchise its real estate brokerage franchise systems under the Century 21, Coldwell Banker, Coldwell Banker Commercial, ERA, Sotheby’s International Realty, and Better Homes and Gardens Real Estate brand names to real estate brokerage businesses.

Finally, Juno Therapeutics Inc. (NASDAQ:JUNO), ended its last trade with -3.97% loss, and closed at $43.28.

Juno Therapeutics, will declare financial results for the first quarter of 2015 on Monday, May 11, 2015 after the close of U.S.-based financial markets. Hans E. Bishop, President and Chief Executive Officer, and Steven D. Harr, Chief Financial Officer, will host a conference call to review the results starting at 2:00 p.m. Pacific Time (PT)/5:00 p.m. Eastern Time (ET).

Juno Therapeutics, Inc., a biopharmaceutical company, engages in developing cell-based cancer immunotherapies. The company develops cell-based cancer immunotherapies based on its chimeric antigen receptor and T cell receptor technologies to genetically engineer T cells to recognize and kill cancer cells.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *